Phe208 and Ile199 in human monoamine oxidase A and B do not determine substrate and inhibitor specificities as in rat

被引:38
作者
Geha, RM
Chen, K
Shih, JC
机构
[1] Univ So Calif, Sch Pharm, Dept Mol Pharmacol & Toxicol, Los Angeles, CA 90089 USA
[2] Univ So Calif, Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90089 USA
关键词
monoamine oxidase; active site; mutant; chimeric;
D O I
10.1046/j.1471-4159.2000.751304.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
It has been reported previously that reciprocally switching Phe(208) and Ile(199) in rat monoamine oxidase (MAO) A and B, respectively, was sufficient to switch their substrate and inhibitor preferences. In this study, the same mutants were made in the human forms of MAO. When compared with MAO A, MAO A-F2081 showed a sixfold decrease in the specificity constant k(cat)/K-m for both the MAO A- and the MAO B-preferring substrates 5-hydroxy tryptamine and beta-phenylethylamine, respectively. The reciprocal point mutant MAO B-1199F had no effect on substrate affinity. To investigate if the region neighboring these two residues is responsible for conferring preferences, we have also made chimeric constructs by reciprocally switching the corresponding amino acid segments 159-214 in MAO A and 150-205 in MAO B. Chimerics MAO AB(159-214)A and MAO BA(150-205)B had small changes in K-m and IC50 values when compared with MAO A and B, respectively, but did not exhibit a preference switch. The results suggest that Phe(208) in MAO A and amino acid segments 159-214 and 150-205 in MAO A and B, respectively, influence the enzyme active site. However, substrate and inhibitor preferences of human MAO A and B are not determined by the respective residues Phe(108) and Ile(199) as In rat MAO nor by their neighboring regions.
引用
收藏
页码:1304 / 1309
页数:6
相关论文
共 21 条
[11]  
GRIMSBY J, 1997, NAT GENET, V17, P1
[12]   SOME OBSERVATIONS UPON A NEW INHIBITOR OF MONOAMINE OXIDASE IN BRAIN TISSUE [J].
JOHNSTON, JP .
BIOCHEMICAL PHARMACOLOGY, 1968, 17 (07) :1285-&
[13]  
Knoll J, 1972, Adv Biochem Psychopharmacol, V5, P393
[14]   HUMAN MONOAMINE OXIDASE-A AND OXIDASE-B GENES MAP TO XP11.23 AND ARE DELETED IN A PATIENT WITH NORRIE DISEASE [J].
LAN, NC ;
HEINZMANN, C ;
GAL, A ;
KLISAK, I ;
ORTH, U ;
LAI, E ;
GRIMSBY, J ;
SPARKES, RS ;
MOHANDAS, T ;
SHIH, JC .
GENOMICS, 1989, 4 (04) :552-559
[15]   PROSTHETIC GROUPS OF ANIMAL AMINE OXIDASES [J].
NARA, S ;
IGAUE, I ;
GOMES, B ;
YASUNOBU, KT .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1966, 23 (03) :324-&
[16]   CLONING IN SINGLE-STRANDED BACTERIOPHAGE AS AN AID TO RAPID DNA SEQUENCING [J].
SANGER, F ;
COULSON, AR ;
BARRELL, BG ;
SMITH, AJH ;
ROE, BA .
JOURNAL OF MOLECULAR BIOLOGY, 1980, 143 (02) :161-178
[17]   Monoamine oxidase: From genes to behavior [J].
Shih, JC ;
Chen, K ;
Ridd, MJ .
ANNUAL REVIEW OF NEUROSCIENCE, 1999, 22 :197-217
[18]   A key amino acid responsible for substrate selectivity of monoamine oxidase A and B [J].
Tsugeno, Y ;
Ito, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (22) :14033-14036
[19]   REGIONS OF THE MOLECULE RESPONSIBLE FOR SUBSTRATE-SPECIFICITY OF MONOAMINE-OXIDASE-A AND MONOAMINE-OXIDASE-B - A CHIMERIC ENZYME ANALYSIS [J].
TSUGENO, Y ;
HIRASHIKI, I ;
OGATA, F ;
ITO, A .
JOURNAL OF BIOCHEMISTRY, 1995, 118 (05) :974-980
[20]  
WU HF, 1993, MOL PHARMACOL, V43, P888